Polio Pulse

Polio Pulse provides social listening insights to support GPEI’s polio interventions on disinformation, crisis communication, and strategic communication. Data is monitored from polio-endemic and outbreak countries and geographies classified by GPEI, covering 12 major languages spoken in these regions. The platform is managed by the UNICEF Digital Community Engagement (DCE) team.

High Risk

VAXELIS clinical-trial deaths are stripped of context to portray the vaccine as lethal

Geography
United States
Canada
France
Japan
United Kingdom
Italy
Netherlands
Australia
Spain
New Zealand
Germany
Sweden
Themes
Ingredients
Necessity
Safety and side effects

Analysis

Posts about VAXELIS, a combination childhood vaccine that includes protection against poliovirus, are using selected information from clinical-trial documentation to claim that the vaccine killed six infants. The allegation is often accompanied by assertions that the trials did not use a genuine placebo, that the vaccine contains dangerous or undeclared ingredients, and that it may cause paralysis, neurological injury or sudden infant death.

The narrative begins with information contained in the vaccine’s prescribing documentation. Six deaths were recorded among children who received VAXELIS during two United States studies, while one death was recorded in the control groups. Viral posts omit the number of children participating in each group, the causes and timing of the deaths, the existence of deaths among controls and the investigators’ conclusion that none of the deaths was related to vaccination.

Events documented during a clinical trial are therefore presented as confirmed adverse reactions caused by the vaccine. The use of screenshots from prescribing information reinforces the impression that manufacturers and regulators disclosed serious harm in documents that caregivers were not expected to examine.

The six-in-one format also allows the narrative to move between different vaccine conversations. Although the posts are not always exclusively about polio, the poliovirus component is repeatedly highlighted in lists of ingredients and claims about paralysis. This could undermine both routine combination vaccination and confidence in polio vaccines more broadly.

In endemic and outbreak-affected countries, the narrative may be simplified into claims that polio vaccination kills infants, particularly where caregivers have limited access to clear explanations about adverse-event monitoring and causality.

Recommendations

Do not describe the reported deaths as invented. Acknowledge that deaths were recorded during the studies, then explain that deaths occurred in both vaccine and control groups, that different medical causes were reported and that investigators did not conclude that the vaccine caused them.

Produce a paediatrician-led video, visual explainer or carousel showing how to read the safety section of a vaccine document. Explain the difference between an adverse event, a serious adverse event and an adverse reaction, and why researchers document all serious medical events occurring during a trial regardless of whether the vaccine caused them.

Prepare a short question-and-answer guide for health workers and social mobilisers. The guide should respond respectfully to caregivers who have seen the document, explain why combination vaccines are used and avoid dismissing concerns as ignorance or misinformation. Monitor for shortened versions of the allegation that remove the VAXELIS name and refer only to a “polio vaccine trial.”